Casaevades

Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

Por um escritor misterioso
Last updated 12 março 2025
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
PDF) Spacer acquisition by Type III CRISPR-Cas system during bacteriophage infection of Thermus thermophilus
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
PDF) A nucleus-forming jumbophage evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
IJMS, Free Full-Text
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
IJMS, Free Full-Text
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The Rcs stress response inversely controls surface and CRISPR–Cas adaptive immunity to discriminate plasmids and phages
Recomendado para você
você pode gostar

© 2014-2025 citytv24.com. All rights reserved.